GRIN2B and Alzheimer disease: To further investigate whether MorA exerts anti-AD effects via the NMDAR2B, we used N9 and PC12-H cells for in vitro validation with the addition of MK-801, which blocks the action of NMDAR2B (Zeng et al., 2022b).